Shares of Ingevity Co. (NYSE:NGVT – Get Free Report) have earned a consensus rating of “Hold” from the six ratings firms that are currently covering the firm, Marketbeat Ratings reports. Four analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $53.00.
NGVT has been the subject of a number of research reports. Loop Capital upped their price target on shares of Ingevity from $49.00 to $56.00 and gave the stock a “hold” rating in a research report on Tuesday. Wells Fargo & Company upped their target price on Ingevity from $43.00 to $50.00 and gave the stock an “equal weight” rating in a research report on Friday, February 23rd. Jefferies Financial Group upgraded Ingevity from a “hold” rating to a “buy” rating and raised their target price for the company from $52.00 to $62.00 in a report on Monday, April 22nd. Finally, Oppenheimer boosted their price target on Ingevity from $50.00 to $58.00 and gave the stock an “outperform” rating in a research report on Thursday, May 2nd.
Get Our Latest Stock Report on NGVT
Institutional Investors Weigh In On Ingevity
Ingevity Price Performance
Shares of Ingevity stock opened at $53.70 on Wednesday. The stock has a market capitalization of $1.95 billion, a P/E ratio of -17.27 and a beta of 1.79. The company has a current ratio of 1.90, a quick ratio of 0.98 and a debt-to-equity ratio of 2.48. The business’s fifty day moving average price is $47.24 and its 200 day moving average price is $44.38. Ingevity has a twelve month low of $36.66 and a twelve month high of $66.18.
Ingevity (NYSE:NGVT – Get Free Report) last posted its earnings results on Wednesday, May 1st. The company reported $0.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.15. The firm had revenue of $340.10 million during the quarter, compared to the consensus estimate of $319.15 million. Ingevity had a negative net margin of 6.84% and a positive return on equity of 18.65%. The company’s revenue was down 13.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.09 EPS. As a group, research analysts anticipate that Ingevity will post 3.78 earnings per share for the current year.
About Ingevity
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.
Further Reading
- Five stocks we like better than Ingevity
- The Most Important Warren Buffett Stock for Investors: His Own
- Garmin Navigates to New Highs Driven By Wearables Trend
- Options Trading – Understanding Strike Price
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- Roth IRA Calculator: Calculate Your Potential Returns
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.